Healthcare technology firm Semler Scientific (Nasdaq: SMLR) is making a bold bet on Bitcoin, unveiling an ambitious plan to grow its holdings from the current 3,808 BTC to 105,000 BTC by the end of 2027. If successful, this would give the company control over 0.5% of Bitcoin’s fixed 21 million supply, placing it among the top institutional holders globally.
Aggressive Growth Targets for 2025–2027
Semler’s roadmap includes hitting 10,000 BTC by the end of 2025, scaling up to 42,000 BTC by the end of 2026, and reaching the final goal of 105,000 BTC by 2027. To fund this expansion, the company plans to leverage a mix of equity, debt financing, and operational cash flow.
To lead the charge, Semler appointed Joe Burnett as Director of Bitcoin Strategy. Burnett brings a strong background in Bitcoin and financial services, having previously worked at Unchained, Blockware Solutions, and EY.
A Growing Trend Among Public Companies
Semler made its first Bitcoin purchase in May 2024 and has since climbed the ranks to become the 13th largest public company holding BTC, according to data from BitBo.
This move reflects a broader trend of corporate adoption of Bitcoin. Japanese firm Metaplanet recently disclosed plans to accumulate 210,000 BTC by 2027, adding further momentum to Bitcoin’s growing role in public company treasuries.
Semler’s strategy marks a shift for healthcare tech firms traditionally focused on medical innovation rather than digital assets. But as Bitcoin increasingly gains recognition as a long-term store of value, companies like Semler are positioning themselves at the forefront of a financial transformation.
